Grupo IMO is a Spanish provider of radiotherapy services for the treatment of cancer, operating exclusively in that specialty. It runs a network of 11 owned centres located in regions including Castilla La Mancha, Murcia, Madrid, Alicante and Seville. The company operates 16 linear accelerators for advanced treatments, including equipment for robotized surgery (Cyberknife) and two Tomotherapy units, and employs a team of about 200 professionals. Grupo IMO received an approximate €20m investment from Nazca Capital through Fund Nazca III. Chairman and Founder Dr. José Samblas and key members of management participated in the deal, reinvesting most of their stakes. The company intends to use the funds to strengthen its balance sheet to continue to grow; the transaction is subject to approval by Spanish anti-trust authorities.

Total raised

$26M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2011